Olfr952, part of the olfactory receptor family 1 subfamily K, is a critical component in the olfactory system of Mus musculus. As a G-protein-coupled receptor (GPCR), Olfr952 is essential in the detection and transduction of odorant molecules, leading to the perception of smell. The receptor features the characteristic 7-transmembrane domain structure of GPCRs, enabling its binding to odorant molecules and the initiation of intracellular signaling cascades. This specialized function of Olfr952 facilitates the olfactory system's ability to discern a wide array of scents, highlighting its importance in olfactory perception. The inhibition of Olfr952's function can be approached either directly or indirectly. Direct inhibition typically entails obstructing the receptor's interaction with odorant molecules, thereby preventing G-protein activation and the resultant signaling pathway. Achieving this requires precise molecular targeting to ensure specificity, given the diverse array of olfactory receptors. Alternatively, indirect inhibition strategies focus on modulating the receptor's activity through influencing related pathways or cellular processes. This could involve altering membrane dynamics or receptor conformation, impacting the receptor's ability to bind ligands or activate G-proteins. Additionally, targeting downstream signaling pathways or regulatory mechanisms of the receptor can also modulate its activity. For example, affecting the pathways that regulate receptor desensitization, internalization, or recycling can significantly alter the receptor's signaling efficacy. The chemicals listed in the table represent potential indirect inhibitors of Olfr952, each acting through distinct mechanisms, such as cytochrome P450 enzyme inhibition, modulation of neurotransmitter receptors, or alteration of G-protein coupling.
Understanding the mechanisms of Olfr952's function and inhibition is key to comprehending the complex dynamics of olfactory transduction. Exploring both direct and indirect inhibitory strategies sheds light on the modulation of GPCR activity, particularly within the context of olfactory receptors. This knowledge not only advances our understanding of olfactory perception but also contributes to the broader field of GPCR research, which has significant implications in sensory biology and pharmacology. The study of inhibitors of Olfr952 and similar receptors aids in developing a comprehensive understanding of the molecular dynamics governing olfactory signaling and the potential for targeted modulation of these processes.
SEE ALSO...
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Itraconazole | 84625-61-6 | sc-205724 sc-205724A | 50 mg 100 mg | $76.00 $139.00 | 23 | |
Itraconazole, an antifungal agent, inhibits cytochrome P450 enzymes, impacting steroid biosynthesis. This alteration may affect GPCR function, including olfactory receptors like Olfr952, by changing membrane lipid composition and receptor conformation. | ||||||
Nebivolol | 99200-09-6 | sc-279910 | 100 mg | $803.00 | 1 | |
Nebivolol, a selective beta-1 adrenergic receptor blocker, affects GPCR signaling indirectly. By blocking beta-1 receptors, it can alter G-protein coupling in related GPCRs, potentially impacting Olfr952 function. | ||||||
Risperidone | 106266-06-2 | sc-204881 sc-204881A sc-204881B sc-204881C | 10 mg 50 mg 1 g 5 g | $171.00 $705.00 $1000.00 $2000.00 | 1 | |
Risperidone, an atypical antipsychotic, acts on various neurotransmitter receptors, including GPCRs. Its broad receptor interaction profile can lead to modulation of GPCR pathways, indirectly affecting Olfr952 activity in olfaction. | ||||||
Desipramine hydrochloride | 58-28-6 | sc-200158 sc-200158A | 100 mg 1 g | $65.00 $115.00 | 6 | |
Desipramine, a tricyclic antidepressant with histamine and serotonin antagonist properties, affects GPCR modulation. This can indirectly impact the signaling of receptors like Olfr952 by altering the GPCR milieu. | ||||||
Tropisetron hydrochloride | 105826-92-4 | sc-204930 sc-204930A | 10 mg 50 mg | $96.00 $571.00 | 2 | |
Tropisetron, a selective serotonin 5-HT3 receptor antagonist, indirectly affects GPCR signaling pathways. Its action on serotonin receptors can influence G-protein coupling in receptors like Olfr952, altering their signal transduction. | ||||||
(RS)-Atenolol | 29122-68-7 | sc-204895 sc-204895A | 1 g 10 g | $77.00 $408.00 | 1 | |
Atenolol, a selective beta-1 adrenergic receptor blocker, affects GPCR signaling indirectly. By blocking beta-1 receptors, it can alter G-protein coupling in related GPCRs, potentially impacting Olfr952 function. | ||||||
Omeprazole | 73590-58-6 | sc-202265 | 50 mg | $66.00 | 4 | |
Omeprazole, a proton pump inhibitor, can indirectly modulate GPCR activity. By influencing gastric acid secretion, it impacts the histamine-mediated modulation of GPCRs, potentially affecting Olfr952 signaling. | ||||||
Metoprolol Tartrate | 56392-17-7 | sc-205751 sc-205751A | 5 g 25 g | $105.00 $238.00 | 3 | |
Metoprolol, a selective beta-1 adrenergic receptor blocker, modulates GPCR signaling pathways indirectly. Its action on beta-1 receptors can affect G-protein coupling in related GPCRs, potentially impacting Olfr952. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $367.00 | ||
Verapamil, a calcium channel blocker, can influence GPCR function indirectly. By modulating calcium influx, it affects GPCR-mediated signaling, potentially impacting receptors like Olfr952. |